The factors that influence the diagnostic accuracy and sample adequacy of EUS-guided tissue acquisition for the diagnosis of solid pancreatic lesions
Endoscopic Ultrasound · 2024-05 · 13 (3) · 183-189
DOI: 10.1097/eus.0000000000000060 ↗Kurz gefasst
Fachartikel in der Zeitschrift Endoscopic Ultrasound, online erschienen am 05.07.2024. Verfasst von Liqi Sun und 6 weiteren Autor:innen. Beteiligte Einrichtung: Department of Gastroenterology, Changhai Hospital, Navy Military Medical University, Shanghai, China. Die Arbeit wurde bisher 5-mal zitiert (Crossref) und nennt 38 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0).
Abstract (Originalsprache)
Background and Objectives EUS-guided tissue acquisition (EUS-TA) is the preferred method to acquire pancreatic cancer (PC) tissues. The factors associated with false-negative outcomes and inadequate samples should be explored to gain an understanding of EUS-TA.
Methods
The patients who underwent EUS-TA for suspected solid PC but whose results were false-negative were analyzed. The PC patients who underwent EUS-TA with true-positive results on the first day of every month during the study period were selected as the control group. The factors influencing diagnostic accuracy and sample adequacy were explored.
Results
From November 2017 to January 2022, 184 patients were included in the false-negative group, and 175 patients were included in the control group. Multivariate logistic regression demonstrated that the recent acute pancreatitis [odds ratio (OR): 0.478, 95% confidence interval (CI): 0.250–0.914, P = 0.026] and high echo component within the tumor (OR: 0.103, 95% CI: 0.027–0.400, P = 0.001) were independently associated with false-negative EUS-TA results. Meanwhile, using fine-needle biopsy (FNB) needles (OR: 2.270, 95% CI: 1.277–4.035, P = 0.005), more needle passes (OR: 1.651,95% CI: 1.239–2.199, P = 0.005), large tumor size (OR: 1.053, 95% CI: 1.029–1.077, P < 0.001), and high CA-19-9 level (OR: 1.001, 95% CI: 1.000–1.001, P = 0.019) were independently associated with true-positive EUS-TA outcomes. Three needle passes are needed to achieve optimal EUS-TA outcomes. Tumor location in the body/tail (OR: 1.38, 95% CI: 1.01–1.72; P = 0.04), needle passes ≥3 (OR: 1.90; 95% CI: 1.22–2.56; P < 0.001), and using the FNB needle (OR: 2.10; 95%: 1.48–2.85; P < 0.001) were independently related to sample adequacy.
Conclusion
Numerous factors were identified to be associated with the diagnostic accuracy and sample adequacy of EUS-TA.
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of Gastroenterology, Changhai Hospital, Navy Military Medical University, Shanghai, China.
- Department of Gastroenterology, 72th Group Army Hospital, Huzhou University, Huzhou, Zhejiang Province, China.
Zitieren
APA
Sun, L., Li, Y., Song, Q., Peng, L., Xing, Y., Huang, H., & Jin, Z. (2024). The factors that influence the diagnostic accuracy and sample adequacy of EUS-guided tissue acquisition for the diagnosis of solid pancreatic lesions. Endoscopic Ultrasound, 13(3), 183-189. https://doi.org/10.1097/eus.0000000000000060
Vancouver
Sun L, Li Y, Song Q, Peng L, Xing Y, Huang H, et al. The factors that influence the diagnostic accuracy and sample adequacy of EUS-guided tissue acquisition for the diagnosis of solid pancreatic lesions. Endoscopic Ultrasound. 2024;13(3):183-189. doi:10.1097/eus.0000000000000060
BibTeX
@article{Sun2024,
author = {Sun, Liqi and Li, Yuqiong and Song, Qiuyue and Peng, Lisi and Xing, Ying and Huang, Haojie and Jin, Zhendong},
title = {The factors that influence the diagnostic accuracy and sample adequacy of EUS-guided tissue acquisition for the diagnosis of solid pancreatic lesions},
journal = {Endoscopic Ultrasound},
year = {2024},
volume = {13},
number = {3},
pages = {183--189},
doi = {10.1097/eus.0000000000000060}
}
EUVIMED